Message Delivery for the Treatment of Posttraumatic Stress Disorder: Longitudinal Observational Study of Symptom Trajectories.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
29 04 2020
Historique:
received: 22 07 2019
accepted: 24 01 2020
revised: 16 12 2019
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 21 10 2020
Statut: epublish

Résumé

Individuals with posttraumatic stress disorder (PTSD) face symptoms that can hinder access to treatment, such as avoidance and guilt. Telemedicine offers a technological solution to increase access to mental health care and overcome barriers to treatment. Although an increasing body of literature focused on synchronous telehealth (eg, live video), no studies have examined the delivery of PTSD treatment via two-way multimedia messages (ie, texting or messaging). The aim of this study was to conduct a longitudinal observation of treatment for PTSD delivered using two-way asynchronous messaging. We also sought to identify individual and treatment characteristics that could predict the observed outcome differences. Outpatients diagnosed with PTSD (N=475) received interventions from licensed therapists, which were delivered via messaging once or more than once per day, 5 days a week for 12 weeks. PTSD symptoms were assessed every 3 weeks using the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-5. Trajectories of PTSD symptoms were identified using growth mixture modeling (GMM). Using logistic regression, the demographic, treatment, and messaging characteristics of patient groups that improved were compared with the characteristics of patient groups that did not improve. The GMM identified 4 trajectories of PTSD symptoms: moderate improvement (197/475, 41.4%), high symptoms (197/475, 41.4%), chronic symptoms (61/475, 12.9%), and acute improvement (20/475, 4.3%). Patients with a clinically significant reduction in PTSD symptoms (231/475, 48.6%) were more likely to communicate via video (odds ratio [OR] 1.01, 95% CI 1.01-1.05; P=.03), have a higher working alliance with their therapist (OR 1.03, 95% CI 1.01-1.05; P=.02), and be at their first treatment experience (OR 2.03, 95% CI 1.18-3.54; P=.01). Treatment adherence was associated with greater therapeutic alliance (OR 1.07, 95% CI 1.03-1.10; P<.001), education (OR 2.13, 95% CI 1.13-4.03; P=.02), and more patient-generated messages per week (OR 1.08, 95% CI 1.04-1.13; P<.001). Multimedia message delivery for PTSD treatment showed symptom-reduction rates similar to traditional forms of treatment delivery, suggesting further study of messaging as a treatment medium. Most patients completed an 8-week course, reflecting the acceptability of messaging interventions. Delivering treatment via two-way messaging offers increased opportunities for widespread access to mental health care.

Sections du résumé

BACKGROUND
Individuals with posttraumatic stress disorder (PTSD) face symptoms that can hinder access to treatment, such as avoidance and guilt. Telemedicine offers a technological solution to increase access to mental health care and overcome barriers to treatment. Although an increasing body of literature focused on synchronous telehealth (eg, live video), no studies have examined the delivery of PTSD treatment via two-way multimedia messages (ie, texting or messaging).
OBJECTIVE
The aim of this study was to conduct a longitudinal observation of treatment for PTSD delivered using two-way asynchronous messaging. We also sought to identify individual and treatment characteristics that could predict the observed outcome differences.
METHODS
Outpatients diagnosed with PTSD (N=475) received interventions from licensed therapists, which were delivered via messaging once or more than once per day, 5 days a week for 12 weeks. PTSD symptoms were assessed every 3 weeks using the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-5. Trajectories of PTSD symptoms were identified using growth mixture modeling (GMM). Using logistic regression, the demographic, treatment, and messaging characteristics of patient groups that improved were compared with the characteristics of patient groups that did not improve.
RESULTS
The GMM identified 4 trajectories of PTSD symptoms: moderate improvement (197/475, 41.4%), high symptoms (197/475, 41.4%), chronic symptoms (61/475, 12.9%), and acute improvement (20/475, 4.3%). Patients with a clinically significant reduction in PTSD symptoms (231/475, 48.6%) were more likely to communicate via video (odds ratio [OR] 1.01, 95% CI 1.01-1.05; P=.03), have a higher working alliance with their therapist (OR 1.03, 95% CI 1.01-1.05; P=.02), and be at their first treatment experience (OR 2.03, 95% CI 1.18-3.54; P=.01). Treatment adherence was associated with greater therapeutic alliance (OR 1.07, 95% CI 1.03-1.10; P<.001), education (OR 2.13, 95% CI 1.13-4.03; P=.02), and more patient-generated messages per week (OR 1.08, 95% CI 1.04-1.13; P<.001).
CONCLUSIONS
Multimedia message delivery for PTSD treatment showed symptom-reduction rates similar to traditional forms of treatment delivery, suggesting further study of messaging as a treatment medium. Most patients completed an 8-week course, reflecting the acceptability of messaging interventions. Delivering treatment via two-way messaging offers increased opportunities for widespread access to mental health care.

Identifiants

pubmed: 32347814
pii: v22i4e15587
doi: 10.2196/15587
pmc: PMC7221629
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15587

Informations de copyright

©Matteo Malgaroli, Thomas Derrick Hull, Shannon Wiltsey Stirman, Patricia Resick. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 29.04.2020.

Références

Telemed J E Health. 2013 Jun;19(6):444-54
pubmed: 23697504
J Affect Disord. 2014 Jan;152-154:113-21
pubmed: 23886401
Am J Psychiatry. 2005 Feb;162(2):214-27
pubmed: 15677582
Biol Psychiatry. 2002 Sep 15;52(6):610-30
pubmed: 12361671
J Nerv Ment Dis. 2005 Jul;193(7):450-4
pubmed: 15985839
J Med Internet Res. 2015 Mar 20;17(3):e71
pubmed: 25799024
Telemed J E Health. 2017 Mar;23(3):240-247
pubmed: 27797646
J Telemed Telecare. 2016 Jun;22(4):238-43
pubmed: 26231819
J Clin Psychiatry. 2014 May;75(5):470-6
pubmed: 24922484
J Gen Intern Med. 2002 Feb;17(2):103-11
pubmed: 11841525
BMC Psychiatry. 2007 Apr 19;7:13
pubmed: 17442125
J Consult Clin Psychol. 2011 Oct;79(5):629-42
pubmed: 21744945
Depress Anxiety. 2009;26(12):1151-7
pubmed: 19842171
Am J Prev Med. 2009 Feb;36(2):165-73
pubmed: 19135907
J Telemed Telecare. 2012 Jan;18(1):17-9
pubmed: 22052966
Arch Gen Psychiatry. 1995 Dec;52(12):1048-60
pubmed: 7492257
Psychol Trauma. 2016 Jan;8(1):115-21
pubmed: 26098737
J Consult Clin Psychol. 2010 Dec;78(6):974-9
pubmed: 20873895
Clin Psychol Rev. 2018 Jul;63:41-55
pubmed: 29902711
J Affect Disord. 2010 Sep;125(1-3):279-86
pubmed: 20071032
Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9
pubmed: 21332375
Clin Psychol Rev. 2016 Feb;43:128-41
pubmed: 26574151
J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
Psychol Methods. 2011 Mar;16(1):17-33
pubmed: 21381817
J Med Internet Res. 2013 Aug 13;15(8):e165
pubmed: 23942480
Bioinformatics. 2012 Jan 1;28(1):112-8
pubmed: 22039212
N Engl J Med. 1987 Dec 24;317(26):1630-4
pubmed: 3683502
J Rehabil Res Dev. 2012;49(5):679-87
pubmed: 23015579
J Consult Clin Psychol. 2004 Jun;72(3):411-6
pubmed: 15279525
J Clin Psychiatry. 2000;61 Suppl 5:4-12; discussion 13-4
pubmed: 10761674
Perspect Psychol Sci. 2013 Nov;8(6):651-62
pubmed: 26173229
Arch Gen Psychiatry. 1991 Mar;48(3):216-22
pubmed: 1996917
J Clin Psychol. 2011 Jun;67(6):629-38
pubmed: 21360528
Psychol Bull. 2003 Jan;129(1):52-73
pubmed: 12555794
Clin Psychol Rev. 2004 Sep;24(5):583-616
pubmed: 15325746
Psychol Assess. 2016 Nov;28(11):1379-1391
pubmed: 26653052

Auteurs

Matteo Malgaroli (M)

NYU Grossman School of Medicine, New York, NY, United States.

Thomas Derrick Hull (TD)

Columbia University, New York, NY, United States.
Talkspace, New York, NY, United States.

Shannon Wiltsey Stirman (S)

Standford University, Stanford, CA, United States.
National Center for PTSD, Washington DC, DC, United States.

Patricia Resick (P)

Duke University, Durham, NC, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH